-- Creative Biolabs has expanded its primary immune cell portfolio to support the development of 3D tumor microenvironment models for immunotherapy and immuno-oncology research. The expanded offering includes circulating and tissue-associated immune cell types that can be incorporated into in vitro co-culture, spheroid, and organoid workflows.
Constructing a Stratified In Vitro Immune Network
The complexity of the human immune system dictates that simplistic, single-cell-type models may not fully capture the cellular interactions that influence therapeutic responses in vivo. To bridge this translational gap, Creative Biolabs has structured its cell portfolio to support multi-layered, dynamic immune modeling.
For assays requiring foundational immune competency and broad-spectrum profiling, researchers can establish reliable baselines using extensively characterized human peripheral blood mononuclear cells (PBMCs). These robust isolates can provide a useful baseline for immune profiling and selected functional screening applications. However, when experimental protocols demand the precise interrogation of specific mechanistic pathways—such as CAR-T cytotoxicity, antibody-dependent cellular cytotoxicity (ADCC), or macrophage polarization—the platform provides immediate access to rigorously purified immune cell subpopulations. This offering includes highly purified and characterized immune cell populations that support more controlled functional assays.
Addressing the Tissue-Resident Paradigm in Immuno-Oncology
A frequently encountered technical question in advanced 3D tissue modeling concerns the phenotypic discrepancy between systemic circulating immune cells and those situated within solid organ stroma. Specifically, researchers often query why tissue-specific cells are requisite for advanced organoid cultures over standard PBMCs.
Creative Biolabs resolves this by integrating specialized tissue-resident immune cells into its portfolio. These cells can retain selected tissue-associated phenotypic and functional characteristics that may be difficult to reproduce using circulating immune cells alone. Utilizing these specialized cells can be particularly valuable for scientists aiming to accurately model solid tumor infiltration, hepatic immune responses, or dermal inflammatory cascades in 3D spatial biology.
Expert Insight and Clinical Relevance
"The value of advanced 3D tumor models lies in their ability to incorporate more of the cellular complexity found in the tumor microenvironment," said the Director of 3D Cell Technology at Creative Biolabs. "Providing access to both circulating and tissue-associated immune cell populations gives researchers greater flexibility to design fit-for-purpose co-culture models for immuno-oncology studies."
The portfolio also emphasizes cell characterization parameters relevant to reproducible 3D culture workflows, including post-thaw viability, HLA typing where applicable, donor information, and lot-level quality documentation. Primary immune cells can help researchers introduce donor-specific immune phenotypes and functional responses into 3D tumor models, adding biological complexity beyond tumor-only cultures.
About Creative Biolabs
Creative Biolabs is a premier provider of innovative 3D biology and preclinical research solutions. Specializing in advanced in vitro models, the company empowers global researchers with cutting-edge 3D tumor organoids, spheroids, and complex immune co-culture systems.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/3d-biology/
Release ID: 89201394
Google
RSS